We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×

High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery

    Thierry Christophe*

    Institut Pasteur Korea, Screening Technologies & Pharmacology, Sampyeong-dong 696, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea 463–400, Korea

    *Contributed equally to this work

    Search for more papers by this author

    ,
    Fanny Ewann*

    Biology of Intracellular Pathogens - Inserm Avenir, Sampyeong-dong 696, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea 463-400, Korea

    *Contributed equally to this work

    Search for more papers by this author

    ,
    Hee Kyoung Jeon

    Institut Pasteur Korea, Screening Technologies & Pharmacology, Sampyeong-dong 696, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea 463–400, Korea

    ,
    Jonathan Cechetto

    Institut Pasteur Korea, Screening Technologies & Pharmacology, Sampyeong-dong 696, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea 463–400, Korea

    &
    Published Online:https://doi.org/10.4155/fmc.10.223

    Macrophages are reservoirs for replicating mycobacterium during tuberculosis (TB) infections. In this study, small molecules to be developed as anti-tubercular treatments were investigated for their ability to kill intracellular bacteria in in vitro macrophage models. High-content imaging technologies offer a high-throughput method to quantify a drug’s ability to inhibit Mycobacterium tuberculosis intracellular invasion and multiplication in host cells. Dedicated image analysis enables the automated quantification of infected macrophages, and compounds that inhibit mycobacteria proliferation can be tested using this method. Furthermore, the implementation of the assay in 384-well microtiter plates combined with automated image acquisition and analysis allows large-scale screening of compound libraries in M. tuberculosis-infected macrophages. Here we describe a high-throughput and high-content workflow and detail its utility for the development of new TB drugs.

    Bibliography

    • Balganesh TS, Alzari PM, Cole ST. Rising standards for tuberculosis drug development. Trends Pharmacol. Sci.29(11),576–581 (2008).
    • Nguyen L, Pieters J. The trojan horse: survival tactics of pathogenic mycobacteria in macrophages. Trends Cell Biol.15(5),269–276 (2005).
    • Murphy DJ, Brown JR. Novel drug target strategies against Mycobacterium tuberculosis. Curr. Opin. Microbiol.11(5),422–427 (2008).
    • Arain TM, Resconi AE, Singh DC, Stover CK. Reporter gene technology to assess activity of antimycobacterial agents in macrophages. Antimicrob. Agents Chemother.40(6),1542–1544 (1996).
    • Abraham VC, Taylor DL, Haskins JR. High content screening applied to large-scale cell biology. Trends Biotechnol.22(1),15–22 (2004).
    • Trump BF, Berezesky IK. Calcium-mediated cell injury and cell death. FASEB J.9(2),219–228 (1995).
    • Agaisse H, Burrack LS, Philips JA, Rubin EJ, Perrimon N, Higgins DE. Genome-wide RNAi screen for host factors required for intracellular bacterial infection. Science309(5738),1248–1251 (2005).
    • Philips JA, Rubin EJ, Perrimon N. Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection. Science309(5738),1251–1253 (2005).
    • Moon H, Genovesio A. IM.Grid, a grid computing approach for image mining of high throughput-high content screening. In: The 9th IEEE/ACM International Conference on Grid Computing. Tsukuba, Japan, 29 September–1 October 2008.
    • 10  Christophe T, Jackson M, Jeon HK et al. High-content screening identifies decaprenyl-phosphoribose 2´ epimerase as a target for intracellular antimycobacterial inhibitors. PLoS Pathog.5(10),e1000645 (2009).
    • 11  Fenistein D, Lenseigne B, Christophe T, Brodin P, Genovesio A. A fast fully automated cell segmentation algorithm for high-throughput and high-content screening. Cytometry A73(10) 958–64. (2008).
    • 12  Lenseigne B, Brodin P, Jeon HK, Christophe T, Genovesio A. Support vector machines for automatic detection of tuberculosis bacteria in confocal microscopy images. Presented at: ISBI’07. Metro Washington DC, USA, 12–15 April 2007.
    • 13  Jayaswal S, Kamal MA, Dua R et al. Identification of host-dependent survival factors for intracellular Mycobacterium tuberculosis through an siRNA screen. PLoS Pathog.6(4),e1000839 (2010).
    • 14  Zhang JH, Chung TD, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high-throughput screening assays. J. Biomol. Screen.4(2),67–73 (1999).
    • 15  Tailleux L, Neyrolles O, Honore-Bouakline S et al. Constrained intracellular survival of Mycobacterium tuberculosis in human dendritic cells. J. Immunol.170(4),1939–1948 (2003).
    • 16  Bermudez LE, Goodman J. Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect. Immun.64(4),1400–1406 (1996).
    • 17  Neyrolles O, Hernandez-Pando R, Pietri-Rouxel F et al. Is adipose tissue a place for Mycobacterium tuberculosis persistence? PLoS ONE1(1),e43 (2006).
    • 18  Barry CE 3rd, Boshoff HI, Dartois V et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol.7(12),845–855 (2009).
    • 19  Peyron P, Vaubourgeix J, Poquet Y et al. Foamy macrophages from tuberculous patients’ granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog4(11),e1000204 (2008).